Subclinical damage to the nigrostriatal dopamine system by MPTP as a model of preclinical Parkinson's disease: A review
- 1 October 1991
- journal article
- review article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 84 (S136) , 29-36
- https://doi.org/10.1111/j.1600-0404.1991.tb05017.x
Abstract
The study of subtle changes in motor and cognitive function after exposure to MPTP might serve as a guide to the very earliest stages of Parkinson's disease. Studies in nonhuman primates and man exposed to MPTP who remained asymptomatic or recovered completely are reviewed. The question of the relationship between the degree and extent of damage to the nigrostriatal dopamine system and changes in motor and cognitive (behavioral) function is addressed. What guidance they provide in the study of subclinical or preclinical Parkinson's disease is discussed.Keywords
This publication has 22 references indexed in Scilit:
- MPTP reduces dopamine and norepinephrine concentrations in the supplementary motor area and cingulate cortex of the primateNeuroscience Letters, 1990
- Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeysBrain Research, 1990
- COGNITIVE AND MOTOR DEFICITS IN THE ACQUISITION OF AN OBJECT RETRIEVAL/DETOUR TASK IN MPTP-TREATED MONKEYSBrain, 1990
- Amine accumulation, catecholamine depletion and motor impairment in Macaca fasicularis and the C-57 black mouse after MPTP administrationProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1988
- Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeysSynapse, 1988
- MPTP, impairment of motor performance and amine accumulation in Macaca fasicularisBrain Research Bulletin, 1987
- Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSFBrain Research, 1987
- Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatumLife Sciences, 1987
- Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeysNeuroscience, 1986